What the company does
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
What the weekly tape is saying
DXB closed the latest completed week at 0.17 AUD. The 4-week return is -25.0% and the 12-week return is -49.2%. Trend Signal is inactive, Market Dynamics is -1.22. Setup signature: Risk-first tape with a 10/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.40 AUD
- Vs Trend Line
- -58.8%
- Fair Value
- 0.37 AUD
- Vs Fair Value
- -55.2%
- 52W High
- 0.67 AUD
- 52W Low
- 0.16 AUD
- Drawdown
- -75.2%
- Range Position
- 1.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 12
- 52W Active Breadth
- 23.1%
- Sector Scope
- AU Healthcare
- Sector Rank
- 103 of 146
- Sector Percentile
- 29.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AU Healthcare
- Tracked Peers
- 100
- 4W Rank
- 91 of 100
- Avg 1W
- -1.4%
- Avg 4W
- -3.6%
- Trend Breadth
- 15.0%
- Positive MD
- 39.0%
AU Biotechnology
- Tracked Peers
- 47
- 4W Rank
- 42 of 47
- Avg 1W
- -0.1%
- Avg 4W
- -5.8%
- Trend Breadth
- 10.6%
- Positive RS
- 21.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.22
- 4W MD Change
- -17.8%
- Relative Strength
- -63.39
- 4W RS Change
- -18.6%
- Expectation
- Negative
- Probability
- 37.02%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 5.1M
- 13W Average
- 9.6M
- 52W Average
- 7.3M
- Vs 13W
- 0.5x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 13.0%
- 52W Volatility
- 8.8%
- Upside Weeks
- 18
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 5.8% / -7.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- ASX
- Country
- AU
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- AUD
- Market Cap
- 111.1M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.17 AUD | -5.7% | 0.40 AUD | 0.37 AUD | -1.22 | -63.39 | 5.1M | Off |
| 5 Jun 2026 | 0.17 AUD | -5.4% | 0.41 AUD | 0.37 AUD | -1.21 | -60.99 | 9.3M | Off |
| 29 May 2026 | 0.18 AUD | -9.8% | 0.42 AUD | 0.37 AUD | -1.20 | -59.94 | 9.6M | Off |
| 22 May 2026 | 0.20 AUD | -6.8% | 0.43 AUD | 0.37 AUD | -1.13 | -55.98 | 7.5M | Off |
| 15 May 2026 | 0.22 AUD | 2.3% | 0.44 AUD | 0.37 AUD | -1.04 | -53.43 | 12.6M | Off |
| 8 May 2026 | 0.21 AUD | 0.0% | 0.45 AUD | 0.36 AUD | -0.85 | -55.80 | 15.1M | Off |
| 1 May 2026 | 0.21 AUD | -43.4% | 0.46 AUD | 0.36 AUD | -0.96 | -56.56 | 40.0M | Off |
| 24 Apr 2026 | 0.38 AUD | -3.8% | 0.47 AUD | 0.36 AUD | -1.12 | -25.41 | 3.2M | Off |
| 17 Apr 2026 | 0.40 AUD | 16.2% | 0.48 AUD | 0.36 AUD | -1.33 | -24.20 | 6.7M | Off |
| 10 Apr 2026 | 0.34 AUD | 6.3% | 0.48 AUD | 0.36 AUD | -1.61 | -35.07 | 2.7M | Off |
| 3 Apr 2026 | 0.32 AUD | -1.5% | 0.49 AUD | 0.36 AUD | -1.56 | -36.47 | 4.4M | Off |
| 27 Mar 2026 | 0.33 AUD | 0.0% | 0.49 AUD | 0.36 AUD | -1.34 | -35.36 | 3.4M | Off |
| 20 Mar 2026 | 0.33 AUD | -7.1% | 0.50 AUD | 0.35 AUD | -1.22 | -35.02 | 5.8M | Off |
| 13 Mar 2026 | 0.35 AUD | -13.6% | 0.50 AUD | 0.35 AUD | -1.13 | -32.03 | 6.9M | Off |